SPG46 has an early childhood onset, and disease manifestations include muscle weakness and spasticity in upper and lower limbs, ataxia, axonal neuropathy, cognitive impairment, thin corpus callosum, and cerebellar and cerebral atrophy [18, 21, 23, 25]. The gene discussed is GBA2; the disease is Ataxia.